Division of Medical Oncology, Severance Hospital, Yonsei University Health System

Seoul 03722

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, MELANOMA, NSCLC, OTHER SOLID TUMORS, OVCA, Part 1, Part 1 and 2, SARCOMA, SCCHN, UROTHELIAL CARCINOMA

Studies at this site

• A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC — Running, not enrolling
• A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors — Completed